Trial Profile
Anti-coagulation effect of aspirin, LMWH and rivaroxaban after total knee arthroplasty: a prospective randomised control trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Low molecular weight heparins (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- 03 Jul 2018 New trial record